CTLA4 and cancer: The concept of checkpoint inhibition lies within mounting and stimulating one’s immunity against cancer, through inhibiting discovered inhibitory checkpoints such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein-1 (PD-1), and programmed cell-death protein ligand-1 (PDL-1) [1].